Global Cell-Free Fetal DNA Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Cell-Free Fetal DNA Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cell-Free Fetal DNA Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cell-Free Fetal DNA Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell-Free Fetal DNA Testing market has been segmented into:
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity testing
Others
By Application, Cell-Free Fetal DNA Testing has been segmented into:
Hospital
Clinic Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell-Free Fetal DNA Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell-Free Fetal DNA Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell-Free Fetal DNA Testing market.
The report offers in-depth assessment of the growth and other aspects of the Cell-Free Fetal DNA Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell-Free Fetal DNA Testing Market Share Analysis
Cell-Free Fetal DNA Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell-Free Fetal DNA Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell-Free Fetal DNA Testing sales, revenue and market share for each player covered in this report.
The major players covered in Cell-Free Fetal DNA Testing are:
Sequenom Laboratories
Arup Laboratories
Illumina, Inc.
Ariosa Diagnostics
Apollo Path labs
The Fetal Medicine Centre
Table of Contents
1 Cell-Free Fetal DNA Testing Market Overview
1.1 Product Overview and Scope of Cell-Free Fetal DNA Testing
1.2 Classification of Cell-Free Fetal DNA Testing by Type
1.2.1 Global Cell-Free Fetal DNA Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Type in 2019
1.2.3 Abnormal Chromosome Number Detection
1.2.4 Gender Testing
1.2.5 Paternally Inherited Disorder Detection
1.2.6 Paternity testing
1.2.7 Others
1.3 Global Cell-Free Fetal DNA Testing Market by Application
1.3.1 Overview: Global Cell-Free Fetal DNA Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic Center
1.4 Global Cell-Free Fetal DNA Testing Market by Regions
1.4.1 Global Cell-Free Fetal DNA Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell-Free Fetal DNA Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell-Free Fetal DNA Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell-Free Fetal DNA Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell-Free Fetal DNA Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell-Free Fetal DNA Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell-Free Fetal DNA Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sequenom Laboratories
2.1.1 Sequenom Laboratories Details
2.1.2 Sequenom Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sequenom Laboratories SWOT Analysis
2.1.4 Sequenom Laboratories Product and Services
2.1.5 Sequenom Laboratories Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arup Laboratories
2.2.1 Arup Laboratories Details
2.2.2 Arup Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arup Laboratories SWOT Analysis
2.2.4 Arup Laboratories Product and Services
2.2.5 Arup Laboratories Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina, Inc.
2.3.1 Illumina, Inc. Details
2.3.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina, Inc. SWOT Analysis
2.3.4 Illumina, Inc. Product and Services
2.3.5 Illumina, Inc. Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ariosa Diagnostics
2.4.1 Ariosa Diagnostics Details
2.4.2 Ariosa Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ariosa Diagnostics SWOT Analysis
2.4.4 Ariosa Diagnostics Product and Services
2.4.5 Ariosa Diagnostics Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Apollo Path labs
2.5.1 Apollo Path labs Details
2.5.2 Apollo Path labs Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Apollo Path labs SWOT Analysis
2.5.4 Apollo Path labs Product and Services
2.5.5 Apollo Path labs Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 The Fetal Medicine Centre
2.6.1 The Fetal Medicine Centre Details
2.6.2 The Fetal Medicine Centre Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 The Fetal Medicine Centre SWOT Analysis
2.6.4 The Fetal Medicine Centre Product and Services
2.6.5 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell-Free Fetal DNA Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell-Free Fetal DNA Testing Players Market Share
3.2.2 Top 10 Cell-Free Fetal DNA Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell-Free Fetal DNA Testing Revenue and Market Share by Regions
4.2 North America Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
4.5 South America Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
5 North America Cell-Free Fetal DNA Testing Revenue by Countries
5.1 North America Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
5.2 USA Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
6 Europe Cell-Free Fetal DNA Testing Revenue by Countries
6.1 Europe Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
6.2 Germany Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
6.3 UK Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
6.4 France Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell-Free Fetal DNA Testing Revenue by Countries
7.1 Asia-Pacific Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
7.2 China Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
7.5 India Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
8 South America Cell-Free Fetal DNA Testing Revenue by Countries
8.1 South America Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
8.2 Brazil Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell-Free Fetal DNA Testing by Countries
9.1 Middle East & Africa Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell-Free Fetal DNA Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Cell-Free Fetal DNA Testing Market Forecast by Type (2019-2024)
10.3 Abnormal Chromosome Number Detection Revenue Growth Rate (2015-2025)
10.4 Gender Testing Revenue Growth Rate (2015-2025)
10.5 Paternally Inherited Disorder Detection Revenue Growth Rate (2015-2025)
10.6 Paternity testing Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Cell-Free Fetal DNA Testing Market Segment by Application
11.1 Global Cell-Free Fetal DNA Testing Revenue Market Share by Application (2015-2020)
11.2 Cell-Free Fetal DNA Testing Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Center Revenue Growth (2015-2020)
12 Global Cell-Free Fetal DNA Testing Market Size Forecast (2021-2025)
12.1 Global Cell-Free Fetal DNA Testing Market Size Forecast (2021-2025)
12.2 Global Cell-Free Fetal DNA Testing Market Forecast by Regions (2021-2025)
12.3 North America Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
12.4 Europe Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
12.6 South America Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Cell-Free Fetal DNA Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell-Free Fetal DNA Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell-Free Fetal DNA Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell-Free Fetal DNA Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sequenom Laboratories Corporate Information, Location and Competitors
Table 6. Sequenom Laboratories Cell-Free Fetal DNA Testing Major Business
Table 7. Sequenom Laboratories Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2017-2018)
Table 8. Sequenom Laboratories SWOT Analysis
Table 9. Sequenom Laboratories Cell-Free Fetal DNA Testing Product and Solutions
Table 10. Sequenom Laboratories Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Arup Laboratories Corporate Information, Location and Competitors
Table 12. Arup Laboratories Cell-Free Fetal DNA Testing Major Business
Table 13. Arup Laboratories Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2018-2019)
Table 14. Arup Laboratories SWOT Analysis
Table 15. Arup Laboratories Cell-Free Fetal DNA Testing Product and Solutions
Table 16. Arup Laboratories Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina, Inc. Corporate Information, Location and Competitors
Table 18. Illumina, Inc. Cell-Free Fetal DNA Testing Major Business
Table 19. Illumina, Inc. Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2017-2018)
Table 20. Illumina, Inc. SWOT Analysis
Table 21. Illumina, Inc. Cell-Free Fetal DNA Testing Product and Solutions
Table 22. Illumina, Inc. Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Ariosa Diagnostics Corporate Information, Location and Competitors
Table 24. Ariosa Diagnostics Cell-Free Fetal DNA Testing Major Business
Table 25. Ariosa Diagnostics Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2017-2018)
Table 26. Ariosa Diagnostics SWOT Analysis
Table 27. Ariosa Diagnostics Cell-Free Fetal DNA Testing Product and Solutions
Table 28. Ariosa Diagnostics Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Apollo Path labs Corporate Information, Location and Competitors
Table 30. Apollo Path labs Cell-Free Fetal DNA Testing Major Business
Table 31. Apollo Path labs Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2017-2018)
Table 32. Apollo Path labs SWOT Analysis
Table 33. Apollo Path labs Cell-Free Fetal DNA Testing Product and Solutions
Table 34. Apollo Path labs Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. The Fetal Medicine Centre Corporate Information, Location and Competitors
Table 36. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Major Business
Table 37. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Total Revenue (USD Million) (2017-2018)
Table 38. The Fetal Medicine Centre SWOT Analysis
Table 39. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Product and Solutions
Table 40. The Fetal Medicine Centre Cell-Free Fetal DNA Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Cell-Free Fetal DNA Testing Revenue (Million USD) by Players (2015-2020)
Table 42. Global Cell-Free Fetal DNA Testing Revenue Share by Players (2015-2020)
Table 43. Global Cell-Free Fetal DNA Testing Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Cell-Free Fetal DNA Testing Revenue Market Share by Regions (2015-2020)
Table 45. North America Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
Table 46. North America Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Table 47. Europe Cell-Free Fetal DNA Testing Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Cell-Free Fetal DNA Testing Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Cell-Free Fetal DNA Testing Revenue by Countries (2015-2020)
Table 50. South America Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Cell-Free Fetal DNA Testing Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Table 53. Global Cell-Free Fetal DNA Testing Revenue (Million USD) by Type (2015-2020)
Table 54. Global Cell-Free Fetal DNA Testing Revenue Share by Type (2015-2020)
Table 55. Global Cell-Free Fetal DNA Testing Revenue Forecast by Type (2021-2025)
Table 56. Global Cell-Free Fetal DNA Testing Revenue by Application (2015-2020)
Table 57. Global Cell-Free Fetal DNA Testing Revenue Share by Application (2015-2020)
Table 58. Global Cell-Free Fetal DNA Testing Revenue Forecast by Application (2021-2025)
Table 59. Global Cell-Free Fetal DNA Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell-Free Fetal DNA Testing Picture
Figure 2. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type in 2019
Figure 3. Abnormal Chromosome Number Detection Picture
Figure 4. Gender Testing Picture
Figure 5. Paternally Inherited Disorder Detection Picture
Figure 6. Paternity testing Picture
Figure 7. Others Picture
Figure 8. Cell-Free Fetal DNA Testing Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Center Picture
Figure 11. Global Cell-Free Fetal DNA Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cell-Free Fetal DNA Testing Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cell-Free Fetal DNA Testing Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cell-Free Fetal DNA Testing Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cell-Free Fetal DNA Testing Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cell-Free Fetal DNA Testing Revenue Market Share by Regions in 2018
Figure 25. North America Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 28. South America Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 30. North America Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cell-Free Fetal DNA Testing Revenue Market Share by Countries in 2019
Figure 32. USA Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cell-Free Fetal DNA Testing Revenue Market Share by Countries in 2019
Figure 37. Germany Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 38. UK Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 39. France Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cell-Free Fetal DNA Testing Revenue Market Share by Countries in 2019
Figure 44. China Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 47. India Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 49. South America Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cell-Free Fetal DNA Testing Revenue Market Share by Countries in 2019
Figure 51. Brazil Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cell-Free Fetal DNA Testing Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cell-Free Fetal DNA Testing Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cell-Free Fetal DNA Testing Revenue and Growth Rate (2015-2020)
Figure 59. Global Cell-Free Fetal DNA Testing Revenue Share by Type (2015-2020)
Figure 60. Global Cell-Free Fetal DNA Testing Revenue Share by Type in 2019
Figure 61. Global Cell-Free Fetal DNA Testing Market Share Forecast by Type (2021-2025)
Figure 62. Global Abnormal Chromosome Number Detection Revenue Growth Rate (2015-2020)
Figure 63. Global Gender Testing Revenue Growth Rate (2015-2020)
Figure 64. Global Paternally Inherited Disorder Detection Revenue Growth Rate (2015-2020)
Figure 65. Global Paternity testing Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Cell-Free Fetal DNA Testing Revenue Share by Application (2015-2020)
Figure 68. Global Cell-Free Fetal DNA Testing Revenue Share by Application in 2019
Figure 69. Global Cell-Free Fetal DNA Testing Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Clinic Center Revenue Growth Rate (2015-2020)
Figure 72. Global Cell-Free Fetal DNA Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cell-Free Fetal DNA Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cell-Free Fetal DNA Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
Figure 76. Europe Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
Figure 78. South America Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cell-Free Fetal DNA Testing Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Sequenom Laboratories
Arup Laboratories
Illumina, Inc.
Ariosa Diagnostics
Apollo Path labs
The Fetal Medicine Centre
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets